Relating to modification of certain prescription drug benefits and coverage offered by certain health benefit plans.
Relating to modification of certain prescription drug benefits and coverage offered by certain health benefit plans.
Relating to insurance coverage for the disposition of embryonic and fetal tissue remains.
Relating to consideration by insurers of certain prohibited criteria for ratemaking and coverage decisions and the use of disparate impact analysis regarding certain insurance practices.
Relating to availability of and benefits provided under health benefit plan coverage.
Relating to availability of and benefits provided under health benefit plan coverage.
Relating to prohibiting discrimination by financial institutions against lawful companies and businesses in the firearms and ammunition industry.
Relating to prohibiting discrimination by financial institutions against lawful companies and businesses in the firearms and ammunition industry.
Relating to prohibiting financial institutions and other businesses from using value-based criteria.
Relating to health benefit coverage for diagnostic examinations for lung cancer.